Plain-English translation of NCT07726043 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Charcot-Marie-Tooth disease type 1A (CMT1A) is an inherited nerve disorder that weakens muscles in your legs and feet, making balance and walking difficult. This trial is testing whether an intensive rehabilitation program — done with or without a vibration therapy device applied to your tendons — can help improve your balance and reduce falls.
Currently, there is no cure for CMT1A, and people with this condition often struggle with balance problems and falls that affect their quality of life. Rehabilitation programs and newer approaches like vibration therapy show promise, but we need to know which combination works best to help patients stay steady and active.
You likely qualify if…
You likely don't qualify if…
You would be assigned to receive either intensive rehabilitation exercises alone or intensive rehabilitation combined with vibration therapy applied to your leg tendons. Over the course of the trial, you would attend rehabilitation sessions, complete exercises, and be tested on your balance and walking ability. The study involves 30 participants, and you would work closely with rehabilitation specialists to see how the treatment affects your symptoms.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
France